Ph-like acute lymphoblastic leukemia: a high-risk subtype in adultsNitin Jain, Marina Konopleva, Marcus Valentine et al.|Blood|2016Cited by 385
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibitionJan A. Burger, Catherine J. Wu, Dan A. Landau et al.|Nature Communications|2016Cited by 346
10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trialCourtney D. DiNardo, Marina Konopleva, Abhishek Maiti et al.|The Lancet Haematology|2020Cited by 330
Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemiaMarina Konopleva, Hagop Kantarjian, Peter F. Thall et al.|Haematologica|2015Cited by 121
<i><scp>MYC</scp>/<scp>BCL</scp>6</i> double‐hit lymphoma (<scp>DHL</scp>): a tumour associated with an aggressive clinical course and poor prognosisShaoying Li, L. Jeffrey Medeiros, Parth Desai et al.|Histopathology|2015Cited by 106